Development and testing of a new instrument to measure patient satisfaction with health care in inflammatory bowel disease: The CACHE questionnaire

Inflammatory Bowel Diseases

Volumn 19, Issue 3, 2013, Pages 559-568

  Casellas, Francesc ^a   Ginard, Daniel ^b   Vera, Isabel ^c   Torrejón, Antonio ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Development and validation; Health care; Inflammatory bowel disease; Patient satisfaction; Satisfaction questionnaire

Indexed keywords

5 POINT LIKERT SCALE; ADULT; CACHE QUESTIONNAIRE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; EFFECT SIZE; ENTERITIS; FACTORIAL ANALYSIS; FEASIBILITY STUDY; FEMALE; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HUMAN; INTERNAL VALIDITY; INTERRATER RELIABILITY; LIKERT SCALE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; MEDICAL INFORMATION; MEDICAL STAFF; MULTICENTER STUDY; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADULT; FACTOR ANALYSIS, STATISTICAL; FEASIBILITY STUDIES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SPAIN;

EID: 84876359617     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e31827febd1     Document Type: Review

References (28)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369:1641-1657.
2. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627-1640.
3. Saro C, Riestra S, Milla A, et al. Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain. An Med Interna. 2003;20:3-9.
4. López-Serrano P, Pérez-Calle JL, Carrera-Alonso E, et al. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig. 2009;101:768-772.
5. Antón J, Ortega A, Arranz A, et al. Incidence of inflammatory bowel disease in the health area of Navalmoral de la Mata (Caceres, Spain) between 2000 and 2009. Gastroenterol Hepatol. 2010;33:694-699.
6. Arin A, Borda F, Burusco MJ, et al. High incidence rates of inflammatory bowel disease in Navarra (Spain). Results of a prospective, populationbased study. Gastroenterol Hepatol. 2008;31:111-116.
7. VergaraM, Casellas F, Badia X, et al. Assessing the quality of life of household members of patients with inflammatory bowel disease: development and validation of a specific questionnaire. Am J Gastroenterol. 2002;97:1429-1437.
8. Casellas F, Arenas JI, Baudet JS, et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis. 2005;11:488-496.
9. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135:1907-1913.
10. Kappelman MD, Palmer L, Boyle BM, et al. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis. 2010; 16:125-133.
11. Travis SP, Stange EF, Lémann M, et al. European evidence-based Consensus on the management of ulcerative colitis: current management. J Crohns Colitis. 2008;2:24-62.
12. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis. 2010;4:28-62.
13. Cassinotti A, Keshav S, Ardizzone S, et al. IBD care in Europe: a comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool. J Crohns Colitis. 2009;3:291-301.
14. Gisbert JP, Gomollón F, Hinojosa J, et al. Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain. J Crohns Colitis. 2010;4:567-574.
15. Coyne K, Joshua-Gotlib S, Kimel M, et al. Validation of the treatment satisfaction questionnaire for Crohn's disease (TSQ-C). Dig Dis Sci. 2005; 50:252-258.
16. van der Eijk I, Sixma H, Smeets T, et al. Quality of health care in inflammatory bowel disease: development of a reliable questionnaire (QUOTE-IBD) and first results. Am J Gastroenterol. 2001;96:3329-3336.
17. Masachs M, Casellas F, Borruel N, et al. Validation of the Spanish version of a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease (QUOTE-IBD). Inflamm Bowel Dis. 2010;16:982-992.
18. Bland JM, Altman DG. Cronbach's alpha. BMJ. 1997;314:572.
19. Fitzpatrick R. Surveys of patients satisfaction: I-important general considerations. BMJ. 1991;302:887-889.
20. Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly-developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health. 2011;14;967-977.
21. Developing a questionnaire. In: Fayers P, Machin D, eds. Quality of Life: Assessment, Analysis, and Interpretation. Chichester, United Kingdom: Wiley; 2000;51-76.
22. Nunnally JC, Berstein IH. Psychometric Theory. New York, NY: Mc-Graw-Hill; 1994.
23. Bradley C, Plowright R, Stewart J, et al. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ. Health Qual Life Outcomes. 2007;5:57.
24. Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
25. Huamán JW, Casellas F, Borruel N, et al. Cut-off values of the Inflammatory Bowel Disease Questionnaire to predict a normal health related quality of life. J Crohns Colitis. 2010;4:637-641.
26. U.S. Department of Health and Human Services. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. MD: Office of Communications, Division of Drug Information; 2009. Available at: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed January 30, 2013.
27. Wild D, Grove A, Martin M, et al. ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8:94-104.
28. Marín L, Torrejón A, Oltra L, et al. Nursing resources and responsibilities according to hospital organizational model for management of inflammatory bowel disease in Spain. J Crohns Colitis. 2011;5:211-217.